Home/Filings/4/0001140361-22-029135
4//SEC Filing

Georgantas Robert William III 4

Accession 0001140361-22-029135

CIK 0001439725other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 6:54 PM ET

Size

11.8 KB

Accession

0001140361-22-029135

Insider Transaction Report

Form 4
Period: 2022-08-08
Georgantas Robert William III
DirectorSVP, Rsrch & Trans'l Science
Transactions
  • Sale

    Common Stock

    2022-08-09$2.53/sh1,686$4,26322,244 total
  • Exercise/Conversion

    Common Stock

    2022-08-08+5,64723,930 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-08-081,97227,594 total
    Common Stock (1,972 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2022-08-083,67514,702 total
    Common Stock (3,675 underlying)
Holdings
  • Common Stock

    (indirect: By UGMA Account)
    100
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").
  • [F2]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
  • [F3]These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
  • [F4]These Shares were sold automatically to cover taxes upon the vesting of RSUs.
  • [F5]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001827728

Filing Metadata

Form type
4
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:54 PM ET
Size
11.8 KB